Your search returned 193 studies. (Get alerts for new studies):
- A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors
Conditions: Cancer
2 Locations available
- Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
10 Locations available
- Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Kidney Cancer - Liver Cancer - Retinoblastoma - Sarcoma
1 Location available
- Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Conditions: Cancer - Solid Tumor
3 Locations available
- ABT-888 and Cyclophosphamide With Versus Without Doxorubicin in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Conditions: Breast Cancer - Lymphoma - Lymphoproliferative Disorder - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Neuropsychological Measures in Patients Undergoing Radiation Therapy for Brain Metastases
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
Conditions: Cancer - Oncology - Tumors - Advanced Malignancy - Advanced Solid Tumors - Oncology Patients
3 Locations available
- Methionine PET/CT Studies In Patients With Cancer
Conditions: Brain Tumors and /or Solid Tumors Including: - Brain Stem Glioma - High Grade CNS Tumors - Ependymoma - Medulloblastoma - Craniopharyngioma - Low Grade CNS Tumors - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Ewing Sarcoma - Osteosarcoma - Rhabdomyosarcoma
1 Location available
- Stereotactic Body Radiation Therapy and Vertebroplasty in Treating Patients With Localized Spinal Metastasis
Conditions: Metastatic Cancer - Pain - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Pancreatic Cancer - Peritoneal Cavity Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Pr
1 Location available
- Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
Conditions: Fatigue - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Study of HF10 in Patients With Refractory Head and Neck Cancer or Solid Tumors With Cutaneous and/or Superficial Lesions
Conditions: Refractory Head and Neck Cancer, Squamous Cell Carcinoma of the Skin, Carcinoma of the Breast, and Malignant Melanoma
4 Locations available
- Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers
Conditions: Breast Cancer - Neoplasm Metastasis
1 Location available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Breast Cancer - Colorectal Cancer - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Late Effects of Radiation Therapy and Natural History of Disease in Patients Previously Treated for Cancer at the National Institutes of Health
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Breast Imaging Using Indium In 111 CHX-A DTPA Trastuzumab in Patients With Primary Cancer or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Collection of Outcomes Data for Pregnant Patients With Cancer
Conditions: Solid Tumors - Pregnancy
1 Location available
- Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Ipilimumab in Young Patients With Advanced or Refractory Solid Tumors
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Childhood Malignant Fibrous Histiocytoma of Bone - Kidney Cancer - Lymphoma - Melanoma (Skin) - Neuroblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor,
3 Locations available
- Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
Conditions: Advanced Cancer
1 Location available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung
Conditions: Lung Cancer - Non Small Cell Lung Cancer - Solid Tumors
1 Location available
- A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
2 Locations available
- A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffe
Conditions: Solid Cancers
3 Locations available
- GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Conditions: Solid Tumor - Breast Cancer - Ovarian Cancer - Pancreatic Cancer - Non-Small Cell Lung
2 Locations available
- A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Pazopanib and Everolimus in Patients With Advanced Solid Tumors and Previously Treated Kidney Cancer
Conditions: Solid Tumor - Kidney Cancer
2 Locations available
- Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Kidney Cancer - Melanoma (Skin) - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
7 Locations available
- Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Conditions: Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
5 Locations available
- Studying Patients With a Personal or Family History of Cancer Caused by a Virus
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Sarcoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Conditions: Advanced or Metastatic Solid Tumors - Advanced or Metastatic Breast Cancer
1 Location available
- Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Conditions: Solid Tumors - Neoplasms, Breast - Cancer
11 Locations available
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
7 Locations available
- Dose-escalation Study of Oral CX-4945
Conditions: Advanced Solid Tumors - Breast Cancer - Inflammatory Breast Cancer - Castleman's Disease - Multiple Myeloma
4 Locations available
- A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors
Conditions: Advanced or Metastatic Solid Tumors - Cancer - Solid Cancers
4 Locations available
- Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
Conditions: Cancer
3 Locations available
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Conditions: ErbB2 Overexpressing - Solid Tumors - Metastatic Breast Cancer - Neoplasms, Breast
8 Locations available
- Lapatinib and Cetuximab in Patients With Solid Tumors
Conditions: Colorectal Cancer - Lung Cancer - Head and Neck Cancer
1 Location available
- Dose Escalation, Combination Chemotherapy Safety Study of TL32711, in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Cancer
6 Locations available
- Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
Conditions: Recurrence of Solid Tumor - Glioblastoma Multiforme - Melanoma
3 Locations available
- A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Conditions: Metastatic Cancer - Cancer - Solid Tumors
3 Locations available
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Precancerous Condition - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Conditions: Advanced Solid Tumors - Kidney Disease - Renal Impairment
4 Locations available
- Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Neurotoxicity - Radiation Toxicity - Unspecified Adult Solid Tumor, Protocol Specific
17 Locations available
- Cancer Risk in Individuals Who Have a Xeroderma Pigmentosum Gene Alteration Compared With Those Who Don't
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physi
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
Conditions: Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
4 Locations available
- Advanced Care Planning Using the Five Wishes Document in Young Patients With Metastatic, Recurrent, or Progressive Cancer or HIV Disease
Conditions: Psychosocial Effects of Cancer and Its Treatment - Transitional Care Planning - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
2 Locations available
- Assessment Tool for Older Patients With Cancer
Conditions: Cognitive/Functional Effects - Psychosocial Effects of Cancer and Its Treatment - Unspecified Adult Solid Tumor, Protocol Specific
8 Locations available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Computer Program to Find and Diagnose Cancer or Other Diseases Using Radiologic Images
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- A Trial In Patients With Advanced Cancer And Leukemia
Conditions: Neoplasms by Histologic Type - Leukemia, Lymphoid - Leukemia, T-Cell - Solid Tumors
6 Locations available
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
158 Locations available
- Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Cancer - Solid Tumors - Lymphoma - Malignancy
3 Locations available
- Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
Conditions: Sarcoma - Endocrine Tumors - Neuroblastoma - Retinoblastoma - Renal Cancer
2 Locations available
- Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid Tumor
Conditions: Colorectal Cancer
5 Locations available
- Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Conditions: Cachexia - Nausea and Vomiting - Unspecified Childhood Solid Tumor, Protocol Specific - Weight Changes
18 Locations available
- A Database Study for Hematopoietic Stem Cell Transplantation and Marrow Injuries
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Conditions: Bladder Cancer - Renal Pelvis Cancer - Ureter Cancer
1 Location available
- Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Conditions: Advanced Solid Tumors - Metastatic Colorectal Cancer
1 Location available
- AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors - Breast Cancer
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol S
1 Location available
- Screening Study of Patient Eligibility for Participation in National Cancer Institute Radiation Therapy Clinical Trials
Conditions: Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Abraxane and Alimta in Advanced Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
Conditions: Kidney Cancer - Lung Cancer - Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Conditions: Nausea and Vomiting - Unspecified Adult Solid Tumor, Protocol Specific
4 Locations available
- A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
Conditions: Advanced Malignancy - Advanced Solid Tumors - Cancer - Solid Tumors - Tumors
2 Locations available
- Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer - Lung Cancer - Metastatic Cancer - Multiple Myeloma and Plasma Cell Neoplasm - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
440 Locations available
- Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Colorectal Cancer - Head and Neck Cancer - Neoplasm Metastasis
3 Locations available
- Use of Hydralzaine and Valproic Acid in Advanced Solid Tumor Malignancies
Conditions: Lung Cancer
1 Location available
- Intraperitoneal Radioimmunotherapy With 131I-8H9 for Patients With Desmoplastic Small Round Cell Tumors and Other Solid Tumors Involving the Peritoneu
Conditions: Peritoneal Cancer
1 Location available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- A Study to Test Safety and Efficacy of IMGN901 in Combination With Carboplatin/Etoposide in Patients With Advanced Solid Tumors and Extensive Stage Sm
Conditions: Small Cell Lung Cancer and Other Solid Tumors
2 Locations available
- Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Trial of Individual Psychosocial Interventions for Cancer Patients
Conditions: Stage IV Solid Tumor Diseases
1 Location available
- Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors
Conditions: Solid Tumors - Non-Small Cell Lung Cancer (NSCLC)
1 Location available
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour - Breast Cancer - Malignant Tumor of Colon - GIST - Ovarian Cancer
1 Location available
- Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks
Conditions: Major Advanced Solid Tumors Other Than Colorectal
1 Location available
- Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
Conditions: Unspecified Adult Solid Tumor - Protocol Specific - Breast Cancer - Female
1 Location available
- ABC294640 in Treating Patients With Advanced Solid Tumors
Conditions: Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Conditions: Ototoxicity - Unspecified Childhood Solid Tumor, Protocol Specific
73 Locations available
- Irinotecan and ABT-888 in Treating Patients With Metastatic or Unresectable Cancer
Conditions: Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer
Conditions: Breast Cancer, - Advanced Solid Tumors, - Cowden Syndrome
8 Locations available
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Study Evaluating GDC-0980 Administered Once Weekly in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma, Solid Cancers
1 Location available
- Trial of Bi-shRNA-furin and Granulocyte Macrophage Colony Stimulating Factor (GMCSF) Augmented Autologous Tumor Cell Vaccine for Advanced Cancer
Conditions: Solid Tumors
1 Location available
- A Phase 1 Study of MLN8237 in Patients With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regime
Conditions: Advanced Solid Tumors - Adenocarcinoma of the Prostate
1 Location available
- Study of PX-866 and Docetaxel in Solid Tumors
Conditions: Non Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma of the Head and Neck (SCCHN)
28 Locations available
- MEK Inhibitor AZD6244 and Cetuximab Treating Patients With Advanced or Refractory Solid Tumors That Cannot Be Removed By Surgery
Conditions: Colorectal Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Leukemia - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
22 Locations available
- Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms - Ovarian Neoplasms - Fallopian Tube Neoplasms - Primary Peritoneal Neoplasm
5 Locations available
- A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
Conditions: Leukemia/Lymphoma - Solid Tumor - Cancer Therapy
1 Location available
- Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of BMS-663513 in Subjects With Advanced and/or Metastatic Solid Tumors
Conditions: Cancer - Solid Tumors
4 Locations available
- Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer
Conditions: Solid Tumors - Prostate Cancer
1 Location available
- Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy
Conditions: Malignant Neoplasm - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer
Conditions: Advanced Cancer - Metastatic Cancer - Solid Tumors
1 Location available
- Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
Conditions: Solid Tumor - Urethral Cancer
1 Location available
- Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Conditions: Dermatologic Complications - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Biliary Cancer - Pancreatic Cancer
1 Location available
- IDO Inhibitor Study for Relapsed or Refractory Solid Tumors
Conditions: Breast Cancer - Lung Cancer - Melanoma - Pancreatic Cancer - Solid Tumors
1 Location available
- FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
Conditions: Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer - Breast Neoplasms - Breast Tumors - Cancer - Locally Recurrent and Metastatic Breast Cancer - Metastases - Metastatic Cancer - Oncology - Solid Tumors - Tumors
5 Locations available
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
97 Locations available
- A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors
Conditions: Non-Small Cell Lung Cancer, Solid Cancers
2 Locations available
- Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
Conditions: Triple Negative Breast Cancer
1 Location available
- A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Solid Cancers
3 Locations available
- A Study of IMC-RON8 in Advanced Solid Tumors
Conditions: Cancer
2 Locations available
- Bioavailability and Food Effect Study of TKI258 (CSF Capsule vs. FMI Tablet) in Adult Patients With Advanced Solid Tumors
Conditions: Neoplasm - Cancer - Tumors
4 Locations available
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
210 Locations available
- GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
Conditions: Adenocarcinoma of the Pancreas - Advanced Solid Tumors - Cancer - Cancer of Pancreas - Cancer of the Pancreas - Metastases - Metastatic Cancer - Metastatic Pancreatic Cancer - Pancreas Cancer - Pancreatic Cancer - Bone Metastases - Endocrine Cancer - Onco
23 Locations available
- Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors
Conditions: Head and Neck Cancer - Advanced Solid Tumors
1 Location available
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors or Advanced Pancreatic Ca
Conditions: Adenocarcinoma of the Pancreas - Stage III Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Study of PNT2258 in Patients With Advanced Solid Tumors
Conditions: Cancer - Lymphoma - Prostate - Melanoma
1 Location available
- Hormone Blockade in Combination With Targeted Agents
Conditions: Solid Tumors - Advanced Cancer
1 Location available
- MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
Conditions: Advanced Solid Tumors - Tumors - Cancer
1 Location available
- A Study of AMG 337 in Subjects With Advanced Solid Tumors
Conditions: Advanced Malignancy - Advanced Solid Tumors - Cancer - Oncology - Oncology Patients - Tumors
4 Locations available
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Study to Evaluate the Safety and Tolerability of Weekly IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors
Conditions: Cancer
2 Locations available
- Safety and PK Study of RRx-001 in Cancer Subjects
Conditions: Malignant Solid Tumor - Lymphomas
2 Locations available
- Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Conditions: Locally Advanced Solid Tumor - Metastatic Solid Tumor - Breast Cancer - Non Small Cell Lung Cancer - Melanoma - Colorectal Cancer
2 Locations available
- Dose-Escalation and Safety Trial of YN968D1
Conditions: Cancer Patients With Solid Tumors
1 Location available
- BKM120 in Cancers With PIK3CA Activating Mutations
Conditions: Lung Cancer - Breast Cancer - Colorectal Cancer - Cholangiocarcinoma - Solid Tumors
1 Location available
- Erlotinib in Combination With Pralatrexate in Advanced Malignancies
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometri
Conditions: Solid Tumors and Advanced Endometrial Cancer - Endometrial Cancer - Second-line Treatment - VEGF
2 Locations available
- Study Determining the Safety and Tolerability of Combination Therapy With Pazopanib and GSK1120212 in Advanced Solid Tumors Enriched With Patients Wit
Conditions: Solid Tumors - Advanced Thyroid Cancer
2 Locations available
- Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Conditions: Solid Tumors
4 Locations available
- Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors
Conditions: Neoplasms - Cancer
2 Locations available
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
Conditions: Acinar Cell Adenocarcinoma of the Pancreas - Duct Cell Adenocarcinoma of the Pancreas - Recurrent Pancreatic Cancer - Stage IV Pancreatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Locally Advanced or Metastatic Breast or Colorectal Cancer
3 Locations available
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
3 Locations available
- Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma
Conditions: Multiple Myeloma - Non-Hodgkin's Lymphoma - Glioblastoma Multiforme - Head and Neck Squamous Cell Cancer - Triple Negative Breast Cancer - Hormone Receptor-Positive Breast Cancer - Castration-Resistant Prostate Cancer - Ewing's Family of Sarcomas
2 Locations available
- E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and
Conditions: Advanced or Metastatic Solid Tumors - Previously Untreated Gastric Cancer
2 Locations available
- Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Excluding Breast Cancer
7 Locations available
- A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies - CD27 Expressing Solid Tumors - Chronic Lymphocytic Leukemia - Burkett's Lymphoma - Mantle Cell Lymphoma - Primary Lymphoma of the Central Nervous System - Marginal Zone B Cell Lymphoma - Solid Tumor - Metastatic Melan
5 Locations available
- An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
Conditions: Solid Tumor of Epithelial Origin - Gastric Cancer
1 Location available
- Study of ABT-700 in Subjects With Advanced Solid Tumors
Conditions: Subjects With Advanced Solid Tumors (Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer).
3 Locations available
- A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Conditions: Cancer
2 Locations available
- Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Metastatic Breast Cancer - Metastatic Renal Cell Carcinoma
1 Location available
- A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor - Breast Cancer - Ovarian Cancer
2 Locations available
- Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors or Prostate or Kidney Cancer
Conditions: Kidney Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
Conditions: Solid Tumors - Bladder Cancer
1 Location available
- Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Conditions: Colon Cancer - Head and Neck Cancer - Lung Cancer - Lymphoma - Malignant Neoplasm - Melanoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma
Conditions: Solid Cancers
2 Locations available
- MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer
Conditions: Breast Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
Conditions: Colonic Neoplasms - Cancer of the Colon - Colon Cancer - Colon Neoplasms - Colonic Cancer
1 Location available
- Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475
Conditions: Cancer, Solid Tumor
13 Locations available
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms - Neoplasms, Urethral - Ureter Cancer - Cancer of the Urethra - Urethral Cancer
1 Location available
- An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN™ in Subjects With Cancer Who Also Have Impaired Renal Function
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors
Conditions: Advanced Cancers
1 Location available
- Study of Axitinib and Temsirolimus in Solid Tumors
Conditions: Cancer
1 Location available
- L-Arginine Supplements in Treating Women Who Are Cancer Survivors
Conditions: Cancer Survivor - Sexual Dysfunction and Infertility - Sexuality and Reproductive Issues - Unspecified Adult Solid Tumor, Protocol Specific
25 Locations available
- Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Conditions: Kidney Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Phase I Study of Vorinostat and Sorafenib in Advanced Cancer
Conditions: Advanced Solid Tumors
1 Location available
- Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Conditions: MDS - AML - Solid Tumors - Multiple Myeloma - Non-Hodgkin's Lymphoma - Hodgkin's Disease
8 Locations available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- Stereotactic Radiosurgery in Treating Patients With Brain Metastases
Conditions: Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
Conditions: Cancer
1 Location available
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
271 Locations available
- Collecting and Storing Tissue and Fluid Samples From Patients Receiving Standard Care at the National Cancer Institute
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Submission of Stem Cell Transplant Data to CIBMTR and NMDP
Conditions: Autologous Stem Cell Transplantation - Allogeneic Stem Cell Transplantation - Solid Tumors - Blood Cancers
1 Location available
- Study of Blood and/or Urine Samples From Cancer Patients Receiving Radiation Therapy at the National Cancer Institute
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor - Adenocarcinoma of the Colon - Adenocarcinoma of the Rectum - Adult Central Nervous System Germ Cell Tumor - Adult Teratoma - Benign Teratoma - Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - Famili
1 Location available
- 5-Azacytidine and Oxaliplatin With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy
Conditions: Advanced Cancer - Solid Tumor - Lymphoma
1 Location available
- Safety Study of AB0024 in Patients With Advanced Solid Tumors
Conditions: Solid Tumors - Cancer
2 Locations available
- Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Cognitive/Functional Effects - Metastatic Cancer - Unspecified Adult Solid Tumor, Protocol Specific
46 Locations available
- A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor - Anaplastic Thyroid Cancer
1 Location available
- Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Conditions: Advanced Solid Malignant Tumors - Advanced Ovarian Cancer
4 Locations available
- Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Conditions: Solid Tumor - Colorectal Cancer - Endometrial Cancer
3 Locations available
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney
Conditions: Cancer
17 Locations available
- Ginseng on Cancer-Related Fatigue
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
Conditions: Advanced Cancers - Solid Tumors
1 Location available
- Safety and Pharmacology of GDC-0068 in Combination With Either Docetaxel or Fluoropyrimidine Plus Oxaliplatin in Patients With Advanced Solid Tumors
Conditions: Solid Cancers
2 Locations available
- A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers
Conditions: Solid Tumor Cancers
1 Location available
- Dose Escalation Study of INK1117 in Subjects With Advanced Cancer
Conditions: Metastatic Solid Tumors
1 Location available
|